64 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... #Treatment #management ... #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... Antifungal Treatment ... Antifungal Treatment ... Meningoencephalitis #IDSA ... #Treatment #management
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... pulmonary aspergillosis ... #management #pharmacology ... #IDSA
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Infections • Pulmonary ... count <50 • Pulmonary ... regardless of CD4 • Cryptococcal ... of starting OI treatment ... Opportunistic #Infections #management
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Pulmonary Infections ... (Histoplasma, Cryptococcus ... ABG, BDG, Serum Cryptococcal ... #Infections #HIVAIDS ... diagnosis #evaluation #differential
Radiographic appearances of pulmonary diseases in HIV/AIDS Patients
 • Diffuse Interstitial Infiltrates: Pneumocystis jirovecii, M.tuberculosis, Histoplasma
appearances of pulmonary ... Coccidioides spp., Cryptococcus ... Drug toxicity, Pulmonary ... ID_fellows #HIVAIDS ... #differential #
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for effective treatment ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS